PTX3 from vascular endothelial cells contributes to trastuzumab-induced cardiac complications.

Authors:
Xu Z; Gao Z; Fu H; Zeng Y; Jin Y and 11 more

Journal:
Cardiovasc Res

Publication Year: 2023

DOI:
10.1093/cvr/cvad012

PMCID:
PMC10202646

PMID:
36651911

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Cardiovasc Res

Abbreviation: Cardiovasc Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Do patients benefit from omega-3 fatty acids?
Sherratt SCR; Mason RP; Libby P and 2 more (2024) - Transparency Score: 3/6
Dysregulated iron homeostasis in dystrophin-deficient cardiomyocytes: correction by gene editing an…
Andrysiak K; Machaj G; Priesmann D and 10 more (2024) - Transparency Score: 4/6
Innate immune memory in cardiometabolic disease.
Bahrar H; Bekkering S; Stienstra R and 2 more (2024) - Transparency Score: 3/6
New therapies for obesity.
Papamargaritis D; le Roux CW; Holst JJ and 1 more (2024) - Transparency Score: 3/6
TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated…
Rolski F; Tkacz K; Węglarczyk K and 9 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the rna-seq data generated in this study are publicly available in the gene expression omnibus (geo) in entry gse200325. table s5 2 10 statistical analysis was performed using graphpad prism 9. all data"

Code Sharing
Evidence found in paper:

"Conflict of interest: None declared."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (Nos. 81872941 to P.L., 82003862 to Z.X., and 82104315 to H.Y.), Postdoctoral Foundation of Zhejiang Province (ZJ2020038 to Z.X.), and the Fundamental Research Funds for the Central Universities."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025